Frontlight ResearchEarly access
Trial site
Hospital de Clinicas de Passo Fundo
- 8running trials
- 2closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Acute myeloid leukaemia1 trial
- Chronic kidney disease1 trial
- Coronary artery disease1 trial
- Endometrial cancer1 trial
- Melanoma1 trial
- Osteoarthritis1 trial
- Peripheral artery disease1 trial
- Prostate cancer1 trial
- Phase
- Phase 38 trials
- Phase 2/31 trial
- Status
- Active, not recruiting4 trials
- Recruiting4 trials
- Completed2 trials
- Lead sponsor
- Pfizer4 trials
- Amgen1 trial
- BioNTech SE1 trial
- CSL Behring1 trial
- Daiichi Sankyo1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Chronic kidney disease1 recruiting
- Coronary artery disease1 recruiting
- Endometrial cancer1 recruiting
- Peripheral artery disease1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026